Navigation Links
West Coast Clinical Trials Selects OmniComm Systems' TrialOne® Suite to Automate Phase I Clinic Operations
Date:3/2/2011

p an excellent reputation in Phase I over the past ten years and has conducted hundreds of clinical studies involving thousands of volunteers for nationally and internationally recognized pharmaceutical and biotechnology companies.  We are delighted to be partnering with them to offer solutions that will help them continue to improve their service offering."  WCCT and OmniComm have also agreed to a partnership and will collaborate on future development plans for the TrialOne suite.

About OmniCommOmniComm Systems, Inc. (www.OmniComm.com) provides customer-driven Internet solutions to pharmaceutical, biotechnology, research and medical device organizations that conduct life changing clinical trial research. OmniComm's growing base of satisfied customers is a direct result of the company's commitment to deliver products and services that ensure ease of use, faster study build, ease of integration and better performance. OmniComm's pricing model is easily understood and allows companies ranging from small, to large, to maximize their clinical research investments. OmniComm Systems, Inc. has U.S. headquarters in Fort Lauderdale, FL and European headquarters in Bonn, Germany, with satellite offices in New Jersey and the United Kingdom, as well as sales offices throughout the U.S. and Europe.

About West Coast Clinical TrialsWCCT is a privately owned independent Phase I-IV CRO, conveniently located near 3 major airports in Southern California. WCCT was founded by Dr. Kenneth Kim who is board certified in Internal Medicine and Allergy and Asthma.  Conducting trials since 1998, WCCT has been audited by the FDA and numerous pharmaceutical and biotechnology companies. Our location and access to an ethnically diverse population allows us to conduct a wide variety of study designs including ethnic bridging. With 150 beds in two locations and over 40,000 square feet, a well-trained and experienced staff, an
'/>"/>

SOURCE OmniComm Systems, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Life Technologies to Webcast Investor Presentation as Part of the UBS West Coast Life Sciences & Diagnostics Bus Trip
2. Mike Napoli Named New Chairman of Tech Coast Angels, Explains Enhanced Process for Entrepreneurs
3. Tech Coast Angels Funds 31 Deals in 2010 and Highlights Three Profitable Exits
4. Crescent Healthcare Expands East Coast Presence
5. Sudek of Tech Coast Angels Announces Networks Increased Commitment to Entrepreneurship and Innovation Through New Easy-Access Programs
6. Huelva is swallowing up coastal lagoons in Doñana
7. CBI Announces the Agenda for Their West Coast Forum on Clinical Supply Chain Management
8. First Coast Oncology to Offer Next Generation Proton Therapy
9. Orange Coast Urology Offers Advanced In-Office Patient EVOLVE(R) Laser Prostate Treatment
10. Abaxis, Inc. to Present at the Sidoti & Companys Seventh Annual West Coast Emerging Growth Institutional Investor Forum
11. Stemline Therapeutics Licenses Phase I/II Brain Cancer Vaccine - Shows Promise in Clinical Trial Conducted at University of Pittsburgh
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/25/2014)... Oramed Pharmaceuticals Inc. (NASDAQCM: ORMP) ... the development of oral drug delivery systems, announced today ... present at FireRock Capital,s Micro-Cap Conference. ... Tuesday, October 28, 2014 ,Time: 9:15am EST ,Location: The ... , About The FireRock Conference  ...
(Date:10/25/2014)... , Oct 24, 2014 Research ... "Epigenetics Market by Product , Research Area & ... report to their offering. In this ... basis of products, research areas, and end users. The ... report are enzymes, instruments & consumables, kits, and reagents. ...
(Date:10/22/2014)... BOSTON , Oct. 22, 2014  Actavis plc ... pharmaceutical company, and Rhythm, a biopharmaceutical company, today announced ... acquire Rhythm,s wholly owned subsidiary, Rhythm Health, Inc., which ... the treatment of diabetic gastroparesis and other GI functional ... Phase 2 trial of relamorelin for the treatment of ...
(Date:10/22/2014)... Massachusetts (PRWEB) October 22, 2014 ... announced the release of a new infographic, Understanding ... to create a beautifully designed, easy to follow informative ... transmission, areas of outbreak, symptoms and prevention. , "As ... discovered that the 2014 Ebola outbreak represents not only ...
Breaking Biology Technology:Oramed to Present at the FireRock Annual Micro-Cap Conference 2Oramed to Present at the FireRock Annual Micro-Cap Conference 3Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 2Global Epigenetics (VLA, WBA, NBA, RTA, Rotary-Wing Aircraft) Market - Forecast to 2019 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 2Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 3Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 4Actavis Signs Option to Acquire Rhythm Subsidiary and its GI Development Product, Relamorelin 5Involution Studios' Ebola Infographic Provides Key Disease Information and Statistics at a Glance 2
... WALTHAM, Mass., Dec. 14 Lionbridge (Nasdaq: LIOX ... three-year master services agreement with a multi-billion dollar biotech ... approximately 100 countries. With the agreement Lionbridge will become ... content, which includes regulatory, marketing, training, human resources, legal, ...
... ... Engineering’s Powder Flow Tester – helping Brookfield move from sheet metal to a plastic ... ... ThermoFab, a US-based thermoforming company, has completed the delivery of Brookfield Engineering’s Powder Flow ...
... Corporation (Nasdaq: DNDN ) announced today that the underwriters ... their option to purchase an additional 2,250,000 shares of common ... The exercise of the option increases the size of ... stock. Dendreon expects to receive net proceeds from the ...
Cached Biology Technology:Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 2Multi-Billion Dollar Biotech Firm Chooses Lionbridge as Exclusive Translation Provider with Three-Year Master Services Agreement 3Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3
(Date:10/16/2014)... 2014 NXT-ID, Inc. (NASDAQ: NXTD ... authentication company focused on the growing mobile commerce market ... Wocket™, the Smart Wallet, at the 13 th ... leading global conference on the intersection of technology and ... Anderson , founder and publisher of the Strategic News ...
(Date:10/15/2014)... The Ebola virus is spreading rapidly and to an ... experienced in the past and the virus shows a ... been recorded before. For this reason, the German National ... of Science and Engineering, and the Union of the ... statement on the Ebola epidemic today. , In the ...
(Date:10/14/2014)... thieves, prostate cancer tumors scavenge and hoard copper that ... avarice may be a fatal weakness. , Researchers ... prostate cancer cells by delivering a trove of copper ... cells brimming with the mineral, leaving non-cancer cells healthy. ... commercially available for other uses, could soon be tested ...
Breaking Biology News(10 mins):NXT-ID Inc. to Present at 13th Annual FiRe Conference 2NXT-ID Inc. to Present at 13th Annual FiRe Conference 3Academies call for consequences from the Ebola virus epidemic 2Academies call for consequences from the Ebola virus epidemic 3Academies call for consequences from the Ebola virus epidemic 4Academies call for consequences from the Ebola virus epidemic 5Prostate cancer's penchant for copper may be a fatal flaw 2
... epilepsy drug shows promise in an animal model at preventing ... a new study by researchers at the University of Pittsburgh ... early online version of the Proceedings of the National ... reason the chronic and sometimes debilitating condition occurs., An estimated ...
... growing open-access publishers, today announces the launch of a ... broad scope journal covering all specialties, Frontiers in ... platform for the research community to publish high quality ... interactive peer-review enables fast, fair and constructive review of ...
... against Alzheimer,s disease, scientists have focused among other factors ... After all, it is the accumulation of A-beta that causes ... point for the formation of A-beta is APP. Alessia Soldano ... the function of APPL the fruit-fly version of APP ...
Cached Biology News:Pitt team finds mechanism that causes noise-induced tinnitus and drug that can prevent it 2Pitt team finds mechanism that causes noise-induced tinnitus and drug that can prevent it 3Frontiers launches new open-access journal in physics 2Frontiers launches new open-access journal in physics 3A new strategy required in the search for Alzheimer's drugs? 2